![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Amgen’s growth over 40 years key to tri-county economy
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/08/23-amgen-web-300x224.gif)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Judge upholds Amgen’s Enbrel patents
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/11/34-amgen-workers-web-300x224.gif)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Judge: Amgen will not have to put drug prices in TV ads
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Arcutis Biotherapeutics starts eczema drug study
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/10/Arcutis-logo-300x184.png)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Tri-county biotech firms tackle COVID-19 pandemic
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/11/34-amgen-workers-web-300x224.gif)
Life sciences companies in the Tri-Counties are stepping up with treatments for COVID-19, led by leaders in inhalable drug technologies. Westlake Village-based MannKind said it expects $4.9 million in forgivable loan relief as part of the CARES Act, passed in March, as it explores four potential anti-infective and antiviral therapies. Separately, aerosolized drug delivery company Read More →
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Sienna Biopharmaceuticals’ struggles doomed company
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/10/30-Sienna-web-300x224.gif)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Sienna set to shut down, lay off remaining staff
![](https://dev.pacbiztimes.com/wp-content/uploads/2017/07/Sienna_Biopharmaceuticals_Inc_Logo-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →